Investor Presentation

View our latest Investor Presentation to find the most recent investor-related information

Latest Financial Results

Q3 2021

Quarter Ended Sep 30, 2021

Company Overview

ProMIS™ Neurosciences, Inc., headquartered in Toronto Ontario, and with offices in Cambridge Massachusetts, is publicly traded on the Toronto Stock Exchange (ticker symbol: PMN.TO) and OTCQB (ticker symbol: ARFXF).ProMIS is a development stage biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the development and progression of neurodegenerative diseases, in particular Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD).

Investor Contact Information


ProMIS Neurosciences, Inc.
1920 Yonge Street
Suite 200
Toronto, ON M4S 3E2
T: 416-847-6898
F: 416-847-6899

Investor Relations

Alpine Equity Advisors
Nicholas Rigopulos
T: 617-901-0785

Transfer Agent

Computershare Canada
1500 Robert Bourassa Boulevard
7th Floor
Montreal, QC H3A 3S8
T: 514-982-7502